DR. KIEKENS

Active

Private limited companyfounded 2004active for 22 yearsGaaiendreef 12, 2900 Schoten, BelgiumKBO/BCE: BE 0864.615.735

From the official registers: KBO 21 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR. KIEKENS has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.2m and a net result of €94,706. Equity is growing by about 7.2% per year across the filed financial years. Its solvency ranks better than 62% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).

Risk analysisFollow Report Compare

DR. KIEKENSActiveChecked score 85/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 08-04-2004 Normal situation
Legal form: Private limited company
Registered office: Gaaiendreef 12, 2900 Schoten
Activity: Specialist medical practice NACE 86220
Establishment units: 2.232.142.026 2800 Mechelen, since 01-04-2004
: 2.232.142.125 2900 Schoten, since 01-07-2007
Financial year end: 30 September
Peppol: Reachable since 05-01-2026

Company details

Who decides

Board

KIEKENS GuntherDirector · since 01-04-2004
ROBBENS Sabrina Mariette WillyDirector · since 30-08-2023

Board & ownership

How it is doing

85 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.3%

Annual accounts to 30-09-2025

Gross margin: €272,808; ▲ 0.2%
Turnover: ≈ €420,000; estimated
Profit: €94,706; ▲ 34.8%
Equity: €1.2m; ▲ 7.7%
Total assets: €1.6m; ▲ 2.6%

2025 accounts 1 day early

Filed on 29-04-2026PDF

Financials

Why 85raises riskLiquidity: current ratio 2.61, cash €128, halvedlowers riskSector: Human health activities (NACE 86)Founded in 2004Equity €1.2m (74.4% of total assets)Show the evidence

Checked score

Score 2025

85 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 38% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 99+3

equity 74.4% of total assets

Liquidity 50=

short-term debt 10.6% · cash 0.0%

Profitability 76+2

return on assets 5.9%

Bankruptcy probability, 12 months

0.3% Very low

0%0.5%1.5%4%10%≥ 25%

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)

Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: 0.1%▲ +0.1 percentage points vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.3%▲ +0.2 percentage points vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.3%● unchanged vs 06-2025 08-2025: 0.3%● unchanged vs 07-2025 09-2025: 0.3%● unchanged vs 08-2025 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.4%▲ +0.1 percentage points vs 03-2026highest value 05-2026: 0.3%▼ -0.1 percentage points vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.3%● unchanged vs 07-2026 09-2026: 0.3%● unchanged vs 08-2026 10-2026: 0.3%● unchanged vs 09-2026

Credit of up to €100,000 on 30-day terms is acceptable

Liquidity ample (current ratio 2.61, compared with 2.18 in 2024, above the usual 1.5; short-term debt: 10.6% and cash: 0% of total assets), and 25.6% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 63% on solvency, 18% on liquidity, 20% on profitability and 49% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises riskneutral

Liquidity: current ratio 2.61, cash €128, halved

NBB · annual accounts

Sector: Human health activities (NACE 86)

KBO

Founded in 2004

Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.

KBO

Equity €1.2m (74.4% of total assets)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 29-04-2026, 1 day ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

1 day early

2024

1 day early

2023

on the day

2022

3 days early

2021

2 days early

2020

2 days early

2019

20 days early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 4 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The financial year that closed on 30-09-2026 is due by 30-04-2027. Nothing is late today. The company usually files around 29 April (5 of the last 5 filed years within 30 days of that day).

Companies Code · seven months

Where today falls in the filing period

30-09-2026 year end01-11-2026 today30-04-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Positive: Among the best 5% on equitysector median €124,628 · 20,680 companies €1.2m View
Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View

Documents

Key facts about DR. KIEKENS

What is the company number of DR. KIEKENS?: 0864.615.735. In Belgium the VAT number is the company number with BE in front: BE 0864.615.735.
Where is DR. KIEKENS based?: The registered office is at Gaaiendreef 12, 2900 Schoten.Company details
What does DR. KIEKENS do?: According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. KIEKENS?: Private limited company (BV).
When was DR. KIEKENS founded?: On 08-04-2004.
Is DR. KIEKENS still active?: Yes, DR. KIEKENS is an active enterprise in the KBO register.
What is the turnover of DR. KIEKENS?: ≈ €420,000 in financial year 2025. Estimated from the gross margin of €272,808: probably between €380,000 and €530,000, based on 36 comparable companies, NACE 862. In financial year 2021 turnover was €409,964.Financials
Is DR. KIEKENS profitable?: In financial year 2025, DR. KIEKENS made a profit of €94,706.
Where can I find the annual accounts of DR. KIEKENS?: DR. KIEKENS filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of DR. KIEKENS due?: By 30-04-2027, for financial year 2026.Timeline